Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion type Assertion NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_head.
- NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion description "[Recent studies have indicated that the loss of p16, an inhibitor of CDK4, promotes the acquisition of malignant characteristics in gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_provenance.
- NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion evidence source_evidence_literature NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_provenance.
- NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion SIO_000772 17273768 NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_provenance.
- NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion wasDerivedFrom befree-20140225 NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_provenance.
- NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_assertion wasGeneratedBy ECO_0000203 NP447729.RAe0s8MA8iQfMpbENJ-Ne2NJbAV_aho6pHhJt1E0itQWM130_provenance.